Click here to get full coverage on VRCA stock outlook for YEAR - Breakout Watch & Low Drawdown Momentum Ideas - newser.com

VRCA stock outlook for YEAR - Breakout Watch & Low Drawdown Momentum Ideas  newser.com

VRCA stock outlook for YEAR - Breakout Watch & Low Drawdown Momentum Ideas - newser.com

Click here to get full coverage on Verrica (NASDAQ: VRCA) presents VP-315 BCC findings: more T-cell infiltration, fewer Tregs - Stock Titan

Verrica (NASDAQ: VRCA) presents VP-315 BCC findings: more T-cell infiltration, fewer Tregs  Stock Titan

Verrica (NASDAQ: VRCA) presents VP-315 BCC findings: more T-cell infiltration, fewer Tregs - Stock Titan

Click here to get full coverage on Verrica Pharmaceuticals (VRCA) Showcases Promising Data for VP-3 - GuruFocus

Verrica Pharmaceuticals (VRCA) Showcases Promising Data for VP-3  GuruFocus

Verrica Pharmaceuticals (VRCA) Showcases Promising Data for VP-3 - GuruFocus

Click here to get full coverage on VRCA stock outlook for YEAR - July 2025 Retail & Technical Confirmation Trade Alerts - newser.com

VRCA stock outlook for YEAR - July 2025 Retail & Technical Confirmation Trade Alerts  newser.com

VRCA stock outlook for YEAR - July 2025 Retail & Technical Confirmation Trade Alerts - newser.com

Click here to get full coverage on Verrica Pharmaceuticals Inc (VRCA) Q2 2025 Earnings Call Highlights: Record Revenue Growth and ... - Yahoo Finance

Verrica Pharmaceuticals Inc (VRCA) Q2 2025 Earnings Call Highlights: Record Revenue Growth and ...  Yahoo Finance

Verrica Pharmaceuticals Inc (VRCA) Q2 2025 Earnings Call Highlights: Record Revenue Growth and ... - Yahoo Finance

Click here to get full coverage on The Technical Signals Behind (VRCA) That Institutions Follow - news.stocktradersdaily.com

The Technical Signals Behind (VRCA) That Institutions Follow  news.stocktradersdaily.com

The Technical Signals Behind (VRCA) That Institutions Follow - news.stocktradersdaily.com

Click here to get full coverage on VERRICA PHARMACEUTICAL Earnings Results: $VRCA Reports Quarterly Earnings - Quiver Quantitative

VERRICA PHARMACEUTICAL Earnings Results: $VRCA Reports Quarterly Earnings  Quiver Quantitative

VERRICA PHARMACEUTICAL Earnings Results: $VRCA Reports Quarterly Earnings - Quiver Quantitative

Click here to get full coverage on Halper Sadeh LLC Encourages Verrica Pharmaceuticals, Inc. Shareholders to Contact the Firm to Discuss Their Rights - Business Wire

Halper Sadeh LLC Encourages Verrica Pharmaceuticals, Inc. Shareholders to Contact the Firm to Discuss Their Rights  Business Wire

Halper Sadeh LLC Encourages Verrica Pharmaceuticals, Inc. Shareholders to Contact the Firm to Discuss Their Rights - Business Wire

Click here to get full coverage on VRCA at Crossroads: Buy or Sell? - StocksToTrade

VRCA at Crossroads: Buy or Sell?  StocksToTrade

VRCA at Crossroads: Buy or Sell? - StocksToTrade

Click here to get full coverage on Naikoon and Kalesnikoff each win VRCA gold for Squamish presentation centre - constructconnect.com

Naikoon and Kalesnikoff each win VRCA gold for Squamish presentation centre  constructconnect.com

Naikoon and Kalesnikoff each win VRCA gold for Squamish presentation centre - constructconnect.com

Click here to get full coverage on Verrica (Nasdaq: VRCA) could file EU MAA for YCANTH as early as Q4 2026 after EMA feedback - Stock Titan

Verrica (Nasdaq: VRCA) could file EU MAA for YCANTH as early as Q4 2026 after EMA feedback  Stock Titan

Verrica (Nasdaq: VRCA) could file EU MAA for YCANTH as early as Q4 2026 after EMA feedback - Stock Titan

Click here to get full coverage on Is VRCA stock trading at a premium valuation - Quarterly Portfolio Summary & Smart Swing Trading Alerts - newser.com

Is VRCA stock trading at a premium valuation - Quarterly Portfolio Summary & Smart Swing Trading Alerts  newser.com

Is VRCA stock trading at a premium valuation - Quarterly Portfolio Summary & Smart Swing Trading Alerts - newser.com

Click here to get full coverage on Verrica Pharmaceuticals Inc. (NASDAQ:VRCA): Are Analysts Optimistic? - Yahoo Finance

Verrica Pharmaceuticals Inc. (NASDAQ:VRCA): Are Analysts Optimistic?  Yahoo Finance

Verrica Pharmaceuticals Inc. (NASDAQ:VRCA): Are Analysts Optimistic? - Yahoo Finance

Click here to get full coverage on Your VRCA 2025 Silver Award winners: B.C. builders go bold - constructconnect.com

Your VRCA 2025 Silver Award winners: B.C. builders go bold  constructconnect.com

Your VRCA 2025 Silver Award winners: B.C. builders go bold - constructconnect.com

Click here to get full coverage on Is VRCA stock trading at a premium valuation - Earnings Beat & Growth Focused Stock Reports - newser.com

Is VRCA stock trading at a premium valuation - Earnings Beat & Growth Focused Stock Reports  newser.com

Is VRCA stock trading at a premium valuation - Earnings Beat & Growth Focused Stock Reports - newser.com

Click here to get full coverage on Verrica Secures $18M in Milestones as Phase 3 Wart Treatment Trial Targets Massive Untapped Market - Stock Titan

Verrica Secures $18M in Milestones as Phase 3 Wart Treatment Trial Targets Massive Untapped Market  Stock Titan

Verrica Secures $18M in Milestones as Phase 3 Wart Treatment Trial Targets Massive Untapped Market - Stock Titan

Click here to get full coverage on ‘One of the most competitive yet’: VRCA’s 36th annual Gold Awards of Excellence winners - constructconnect.com

‘One of the most competitive yet’: VRCA’s 36th annual Gold Awards of Excellence winners  constructconnect.com

‘One of the most competitive yet’: VRCA’s 36th annual Gold Awards of Excellence winners - constructconnect.com

Click here to get full coverage on VRCA stock outlook for YEAR - Trade Volume Report & Short-Term Trading Opportunity Alerts - newser.com

VRCA stock outlook for YEAR - Trade Volume Report & Short-Term Trading Opportunity Alerts  newser.com

VRCA stock outlook for YEAR - Trade Volume Report & Short-Term Trading Opportunity Alerts - newser.com

Click here to get full coverage on Will VRCA stock pay special dividends - 2025 Risk Factors & Technical Buy Zone Confirmations - newser.com

Will VRCA stock pay special dividends - 2025 Risk Factors & Technical Buy Zone Confirmations  newser.com

Will VRCA stock pay special dividends - 2025 Risk Factors & Technical Buy Zone Confirmations - newser.com

Click here to get full coverage on What candlestick patterns are forming on VRCA - Weekly Trend Recap & High Conviction Buy Zone Alerts - newser.com

What candlestick patterns are forming on VRCA - Weekly Trend Recap & High Conviction Buy Zone Alerts  newser.com

What candlestick patterns are forming on VRCA - Weekly Trend Recap & High Conviction Buy Zone Alerts - newser.com

Click here to get full coverage on $10M Milestone Achievement: Verrica's Molluscum Drug YCANTH Receives Landmark Japan Approval via Torii - Stock Titan

$10M Milestone Achievement: Verrica's Molluscum Drug YCANTH Receives Landmark Japan Approval via Torii  Stock Titan

$10M Milestone Achievement: Verrica's Molluscum Drug YCANTH Receives Landmark Japan Approval via Torii - Stock Titan

Click here to get full coverage on Will VRCA stock pay special dividends - Exit Point & Reliable Volume Spike Alerts - Fundação Cultural do Pará

Will VRCA stock pay special dividends - Exit Point & Reliable Volume Spike Alerts  Fundação Cultural do Pará

Will VRCA stock pay special dividends - Exit Point & Reliable Volume Spike Alerts - Fundação Cultural do Pará

Click here to get full coverage on Verrica Pharmaceuticals Receives Positive Feedback from the European Medicines Agency (EMA) Supporting a Clear Regulatory Path Forward to File for Approval of YCANTH® in the European Union - GlobeNewswire

Verrica Pharmaceuticals Receives Positive Feedback from the European Medicines Agency (EMA) Supporting a Clear Regulatory Path Forward to File for Approval of YCANTH® in the European Union  GlobeNewswire

Verrica Pharmaceuticals Receives Positive Feedback from the European Medicines Agency (EMA) Supporting a Clear Regulatory Path Forward to File for Approval of YCANTH® in the European Union - GlobeNewswire

Click here to get full coverage on Verrica Pharmaceuticals Inc (VRCA) Q4 2024 Earnings Call Highlights: Revenue Growth and ... - Yahoo Finance

Verrica Pharmaceuticals Inc (VRCA) Q4 2024 Earnings Call Highlights: Revenue Growth and ...  Yahoo Finance

Verrica Pharmaceuticals Inc (VRCA) Q4 2024 Earnings Call Highlights: Revenue Growth and ... - Yahoo Finance

Click here to get full coverage on Verrica Hits Record Quarter: YCANTH Sales Surge 32.8% as $8M Partnership Milestone Achieved - Stock Titan

Verrica Hits Record Quarter: YCANTH Sales Surge 32.8% as $8M Partnership Milestone Achieved  Stock Titan

Verrica Hits Record Quarter: YCANTH Sales Surge 32.8% as $8M Partnership Milestone Achieved - Stock Titan

Click here to get full coverage on Here's Why Verrica Pharmaceuticals (VRCA) Is a Great 'Buy the Bottom' Stock Now - Nasdaq

Here's Why Verrica Pharmaceuticals (VRCA) Is a Great 'Buy the Bottom' Stock Now  Nasdaq

Here's Why Verrica Pharmaceuticals (VRCA) Is a Great 'Buy the Bottom' Stock Now - Nasdaq

Click here to get full coverage on Textbooks for toolbelts: VRCA touts trades to students - constructconnect.com

Textbooks for toolbelts: VRCA touts trades to students  constructconnect.com

Textbooks for toolbelts: VRCA touts trades to students - constructconnect.com

Click here to get full coverage on 12‑Week Immune Activation: Verrica Presents Phase 2 VP-315 Tumor Microenvironment Data at SITC - Stock Titan

12‑Week Immune Activation: Verrica Presents Phase 2 VP-315 Tumor Microenvironment Data at SITC  Stock Titan

12‑Week Immune Activation: Verrica Presents Phase 2 VP-315 Tumor Microenvironment Data at SITC - Stock Titan

Click here to get full coverage on Custom watchlist performance reports with VRCA - Risk Management & Precise Buy Zone Tips - newser.com

Custom watchlist performance reports with VRCA - Risk Management & Precise Buy Zone Tips  newser.com

Custom watchlist performance reports with VRCA - Risk Management & Precise Buy Zone Tips - newser.com

Click here to get full coverage on Visual trend scoring systems applied to VRCA - Earnings Miss & Breakout Confirmation Alerts - newser.com

Visual trend scoring systems applied to VRCA - Earnings Miss & Breakout Confirmation Alerts  newser.com

Visual trend scoring systems applied to VRCA - Earnings Miss & Breakout Confirmation Alerts - newser.com

Click here to get full coverage on Lucid Capital Initiates Verrica Pharmaceuticals(VRCA.US) With Buy Rating, Announces Target Price $19 - 富途牛牛

Lucid Capital Initiates Verrica Pharmaceuticals(VRCA.US) With Buy Rating, Announces Target Price $19  富途牛牛

Lucid Capital Initiates Verrica Pharmaceuticals(VRCA.US) With Buy Rating, Announces Target Price $19 - 富途牛牛

Click here to get full coverage on Nominations open for VRCA 2025 Outstanding Achievement Awards - constructconnect.com

Nominations open for VRCA 2025 Outstanding Achievement Awards  constructconnect.com

Nominations open for VRCA 2025 Outstanding Achievement Awards - constructconnect.com

Click here to get full coverage on Verrica stock surges after positive EMA feedback on molluscum treatment - Investing.com

Verrica stock surges after positive EMA feedback on molluscum treatment  Investing.com

Verrica stock surges after positive EMA feedback on molluscum treatment - Investing.com

Click here to get full coverage on Verrica Pharmaceuticals Announces That Development Partner, - GlobeNewswire

Verrica Pharmaceuticals Announces That Development Partner,  GlobeNewswire

Verrica Pharmaceuticals Announces That Development Partner, - GlobeNewswire

Click here to get full coverage on Taking the LEAP: VRCA announces Women in Construction Conference 2025 - constructconnect.com

Taking the LEAP: VRCA announces Women in Construction Conference 2025  constructconnect.com

Taking the LEAP: VRCA announces Women in Construction Conference 2025 - constructconnect.com

Click here to get full coverage on VRCA Gains CHMP Support for Ycanth's European Market Authorizati - GuruFocus

VRCA Gains CHMP Support for Ycanth's European Market Authorizati  GuruFocus

VRCA Gains CHMP Support for Ycanth's European Market Authorizati - GuruFocus

Click here to get full coverage on Shareholders May Not Overlook Verrica Pharmaceuticals Insiders Selling US$1.1m In Stock - simplywall.st

Shareholders May Not Overlook Verrica Pharmaceuticals Insiders Selling US$1.1m In Stock  simplywall.st

Shareholders May Not Overlook Verrica Pharmaceuticals Insiders Selling US$1.1m In Stock - simplywall.st

Click here to get full coverage on ‘Summit to Success’: VRCA announces 2025 leadership forum details - constructconnect.com

‘Summit to Success’: VRCA announces 2025 leadership forum details  constructconnect.com

‘Summit to Success’: VRCA announces 2025 leadership forum details - constructconnect.com

Click here to get full coverage on Verrica Pharmaceuticals stock dips after pricing $42M securities offering - MSN

Verrica Pharmaceuticals stock dips after pricing $42M securities offering  MSN

Verrica Pharmaceuticals stock dips after pricing $42M securities offering - MSN

Click here to get full coverage on Is VRCA stock attractive for ETFs - July 2025 WrapUp & Target Return Focused Stock Picks - Fundação Cultural do Pará

Is VRCA stock attractive for ETFs - July 2025 WrapUp & Target Return Focused Stock Picks  Fundação Cultural do Pará

Is VRCA stock attractive for ETFs - July 2025 WrapUp & Target Return Focused Stock Picks - Fundação Cultural do Pará

Click here to get full coverage on Verrica Pharmaceuticals to implement 1-for-10 reverse stock split - Investing.com

Verrica Pharmaceuticals to implement 1-for-10 reverse stock split  Investing.com

Verrica Pharmaceuticals to implement 1-for-10 reverse stock split - Investing.com

Click here to get full coverage on Verrica Pharmaceuticals Receives Positive Feedback From The European Medicines Agency (EMA) Supporting A Clear Regulatory Path Forward To File For Approval Of Ycanth® In The European Union - TradingView

Verrica Pharmaceuticals Receives Positive Feedback From The European Medicines Agency (EMA) Supporting A Clear Regulatory Path Forward To File For Approval Of Ycanth® In The European Union  TradingView

Verrica Pharmaceuticals Receives Positive Feedback From The European Medicines Agency (EMA) Supporting A Clear Regulatory Path Forward To File For Approval Of Ycanth® In The European Union - TradingView

Click here to get full coverage on Verrica receives positive EMA feedback for molluscum treatment filing - Investing.com

Verrica receives positive EMA feedback for molluscum treatment filing  Investing.com

Verrica receives positive EMA feedback for molluscum treatment filing - Investing.com

Click here to get full coverage on VRCA - Verrica Pharmaceuticals Latest Stock News & Market Updates - Stock Titan

VRCA - Verrica Pharmaceuticals Latest Stock News & Market Updates  Stock Titan

VRCA - Verrica Pharmaceuticals Latest Stock News & Market Updates - Stock Titan

Click here to get full coverage on VRCA reveals 2025 Silver Award winners - reminetwork.com

VRCA reveals 2025 Silver Award winners  reminetwork.com

VRCA reveals 2025 Silver Award winners - reminetwork.com

Click here to get full coverage on Will VRCA stock outperform tech sector in 2025 - July 2025 Action & Free Low Drawdown Momentum Trade Ideas - Fundação Cultural do Pará

Will VRCA stock outperform tech sector in 2025 - July 2025 Action & Free Low Drawdown Momentum Trade Ideas  Fundação Cultural do Pará

Will VRCA stock outperform tech sector in 2025 - July 2025 Action & Free Low Drawdown Momentum Trade Ideas - Fundação Cultural do Pará

Click here to get full coverage on Verrica Pharma climbs after EU nod clears path for skin drug filing - TradingView

Verrica Pharma climbs after EU nod clears path for skin drug filing  TradingView

Verrica Pharma climbs after EU nod clears path for skin drug filing - TradingView

Click here to get full coverage on Verrica Pharmaceuticals stock soars after Japan approves YCANTH - Investing.com

Verrica Pharmaceuticals stock soars after Japan approves YCANTH  Investing.com

Verrica Pharmaceuticals stock soars after Japan approves YCANTH - Investing.com

Click here to get full coverage on Verrica Pharmaceuticals to Present New Data on VP-315 from - GlobeNewswire

Verrica Pharmaceuticals to Present New Data on VP-315 from  GlobeNewswire

Verrica Pharmaceuticals to Present New Data on VP-315 from - GlobeNewswire

Click here to get full coverage on How VRCA stock reacts to job market data - Portfolio Profit Report & Long-Term Safe Investment Ideas - Fundação Cultural do Pará

How VRCA stock reacts to job market data - Portfolio Profit Report & Long-Term Safe Investment Ideas  Fundação Cultural do Pará

How VRCA stock reacts to job market data - Portfolio Profit Report & Long-Term Safe Investment Ideas - Fundação Cultural do Pará

Click here to get full coverage on Delta biogas facility earns 2025 VRCA Silver Award - North Delta Reporter

Delta biogas facility earns 2025 VRCA Silver Award  North Delta Reporter

Delta biogas facility earns 2025 VRCA Silver Award - North Delta Reporter

Click here to get full coverage on Verrica Pharmaceuticals (VRCA) Reports Robust Growth in YCANTH S - GuruFocus

Verrica Pharmaceuticals (VRCA) Reports Robust Growth in YCANTH S  GuruFocus

Verrica Pharmaceuticals (VRCA) Reports Robust Growth in YCANTH S - GuruFocus

Click here to get full coverage on Verrica Pharmaceuticals Receives Milestone Payments and Initiates Global Phase 3 Trial for YCANTH® Treatment of Common Warts - Quiver Quantitative

Verrica Pharmaceuticals Receives Milestone Payments and Initiates Global Phase 3 Trial for YCANTH® Treatment of Common Warts  Quiver Quantitative

Verrica Pharmaceuticals Receives Milestone Payments and Initiates Global Phase 3 Trial for YCANTH® Treatment of Common Warts - Quiver Quantitative

Click here to get full coverage on Verrica Pharmaceuticals’ SWOT analysis: stock faces cash crunch amid YCANTH growth - Investing.com

Verrica Pharmaceuticals’ SWOT analysis: stock faces cash crunch amid YCANTH growth  Investing.com

Verrica Pharmaceuticals’ SWOT analysis: stock faces cash crunch amid YCANTH growth - Investing.com

Click here to get full coverage on After Recent Expanded Regulatory Wins For YCANTH, Is Verrica Undervalued? - RTTNews

After Recent Expanded Regulatory Wins For YCANTH, Is Verrica Undervalued?  RTTNews

After Recent Expanded Regulatory Wins For YCANTH, Is Verrica Undervalued? - RTTNews

Click here to get full coverage on Verrica Pharmaceuticals Implements Reverse Stock Split - TipRanks

Verrica Pharmaceuticals Implements Reverse Stock Split  TipRanks

Verrica Pharmaceuticals Implements Reverse Stock Split - TipRanks

Click here to get full coverage on Verrica Pharmaceuticals Regains Nasdaq Compliance - TipRanks

Verrica Pharmaceuticals Regains Nasdaq Compliance  TipRanks

Verrica Pharmaceuticals Regains Nasdaq Compliance - TipRanks

Click here to get full coverage on Verrica’s Japanese partner gets approval for molluscum treatment - Investing.com

Verrica’s Japanese partner gets approval for molluscum treatment  Investing.com

Verrica’s Japanese partner gets approval for molluscum treatment - Investing.com

Click here to get full coverage on VRCA unveils 2025 Silver Award winners - On-Site Magazine

VRCA unveils 2025 Silver Award winners  On-Site Magazine

VRCA unveils 2025 Silver Award winners - On-Site Magazine

Click here to get full coverage on Verrica Pharmaceuticals Reports Strong Growth in YCANTH® Dispensed Applicator Units in 2Q 2025 - Yahoo Finance

Verrica Pharmaceuticals Reports Strong Growth in YCANTH® Dispensed Applicator Units in 2Q 2025  Yahoo Finance

Verrica Pharmaceuticals Reports Strong Growth in YCANTH® Dispensed Applicator Units in 2Q 2025 - Yahoo Finance

Click here to get full coverage on VRCA honours industry’s best - On-Site Magazine

VRCA honours industry’s best  On-Site Magazine

VRCA honours industry’s best - On-Site Magazine

Click here to get full coverage on CSA Strengthens Oversight of Crypto Funds and Launches Regulatory Framework for VRCA - Bitcoinsensus

CSA Strengthens Oversight of Crypto Funds and Launches Regulatory Framework for VRCA  Bitcoinsensus

CSA Strengthens Oversight of Crypto Funds and Launches Regulatory Framework for VRCA - Bitcoinsensus

Click here to get full coverage on VRCA announces 2025 Construction Leadership Forum lineup - On-Site Magazine

VRCA announces 2025 Construction Leadership Forum lineup  On-Site Magazine

VRCA announces 2025 Construction Leadership Forum lineup - On-Site Magazine

Click here to get full coverage on Verrica Pharmaceuticals to Report Second Quarter 2025 Financial Results and Provide a Corporate Update on August 12, 2025 - Yahoo Finance

Verrica Pharmaceuticals to Report Second Quarter 2025 Financial Results and Provide a Corporate Update on August 12, 2025  Yahoo Finance

Verrica Pharmaceuticals to Report Second Quarter 2025 Financial Results and Provide a Corporate Update on August 12, 2025 - Yahoo Finance

Click here to get full coverage on Earnings call transcript: Verrica Pharmaceuticals Q1 2025 results show revenue growth - Investing.com

Earnings call transcript: Verrica Pharmaceuticals Q1 2025 results show revenue growth  Investing.com

Earnings call transcript: Verrica Pharmaceuticals Q1 2025 results show revenue growth - Investing.com

Click here to get full coverage on 2025 Gold winners revealed at VRCA gala - reminetwork.com

2025 Gold winners revealed at VRCA gala  reminetwork.com

2025 Gold winners revealed at VRCA gala - reminetwork.com

Click here to get full coverage on Verrica Pharmaceuticals Amends Collaboration for YCANTH Trial - TipRanks

Verrica Pharmaceuticals Amends Collaboration for YCANTH Trial  TipRanks

VRCA

Price Chart

Key Statistics

Technicals

About VRCA

Latest News

VRCA stock outlook for YEAR - Breakout Watch & Low Drawdown Momentum Ideas - newser.com

Verrica (NASDAQ: VRCA) presents VP-315 BCC findings: more T-cell infiltration, fewer Tregs - Stock Titan

Verrica Pharmaceuticals (VRCA) Showcases Promising Data for VP-3 - GuruFocus

Advanced Charts

Top Gainers

Top Losers